Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature

BACKGROUND: Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastroin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Med Case Rep
Main Authors: Fujii, Yusuke, Hirahara, Noriyuki, Kaji, Syunsuke, Taniura, Takahito, Hyakudomi, Ryoji, Yamamoto, Tetsu, Tajima, Yoshitsugu
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870367/
https://ncbi.nlm.nih.gov/pubmed/29580267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-018-1619-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares